Donna Niedzwiecki

14PUBLICATIONS
112CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsEthical use of new technologyNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Feb 19, 2026
Prognostic Implications of Codon-Specific KRAS Mutations in Localized and Advanced Stages of Pancreatic Cancer.

Sara Raji, Hamed Zaribafzadeh, Tyler Jones

|Jan 08, 2026
Phase II Trial of Interleukin-12 Followed by Interferon Alfa-2b in Patients with Metastatic Malignant Melanoma: Results from CALGB 500001 (Alliance).

Alvin Liu, Courtney Johnson, Donna Niedzwiecki

|Oct 16, 2025
Using Natural Language Processing to Assess Goals-of-Care Conversations for Patients With Cancer.

Melissa K Greene, Gloria Broadwater, Donna Niedzwiecki

|Sep 03, 2025
Randomized Phase II Trial of Pazopanib Versus Placebo in Patients With Advanced Extrapancreatic Neuroendocrine Tumors (Alliance A021202).

Emily K Bergsland, Susan Geyer, Timothy R Asmis

|Jun 08, 2025
Hepatitis C Nucleic Acid Test Positive (NAT+) Solid Organ Consent Rates Are Highest in Patients Listed for Liver Transplant and With an English Language Preference.

|Apr 17, 2025
Improved Survival and Prognostication in Melanoma Patients With Brain Metastases: An Update of the Melanoma Graded Prognostic Assessment.

Paul W Sperduto, Kathryn E Marqueen, Enoch Chang

Pageof 3

Frequent Collaborators

3 joint publications

Jeffrey A Meyerhardt

3 joint publications

Charles S Fuchs

3 joint publications

Alan P Venook

3 joint publications

Fang-Shu Ou